Is ESSBIO-C undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ESSBIO-C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ESSBIO-C (CLP14.7) is trading above our estimate of fair value (CLP11.61)
Significantly Below Fair Value: ESSBIO-C is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ESSBIO-C?
Key metric: As ESSBIO-C is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for ESSBIO-C. This is calculated by dividing ESSBIO-C's market cap by their current
earnings.
What is ESSBIO-C's PE Ratio?
PE Ratio
14.6x
Earnings
CL$26.61b
Market Cap
CL$388.43b
ESSBIO-C key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue
4.1x
Enterprise Value/EBITDA
9.6x
PEG Ratio
n/a
Price to Earnings Ratio vs Peers
How does ESSBIO-C's PE Ratio compare to its peers?
Price-To-Earnings vs Industry: ESSBIO-C is good value based on its Price-To-Earnings Ratio (14.6x) compared to the Global Water Utilities industry average (17x).
Price to Earnings Ratio vs Fair Ratio
What is ESSBIO-C's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
ESSBIO-C PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
14.6x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ESSBIO-C's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.